Every SEC Form 3/4/5 on record for this filer (CIK 1860279) — 2 issuers, 25 transactions. Section-16 filings only: what they filed, not a biography, and titles are as filed on their latest form at each issuer.
| Ticker | Company | Role as filed | On file | Forms | Open-market net |
|---|---|---|---|---|---|
| LH | LABCORP HOLDINGS INC. | Chief Financial Officer, EVP | 2024-12-03 → 2026-02-13 | 7 | — |
| BGNE | BeiGene, Ltd. | Chief Financial Officer | 2021-07-01 → 2024-07-03 | 16 | −$1M |
| Ticker | Date | Action | Shares | Price | Value | Held after |
|---|---|---|---|---|---|---|
| BGNE | 2024-07-01 | Sell | 472 | $143.90 | $67,921 | — |
| BGNE | 2024-06-24 | Sell | 899 | $155.66 | $139,938 | — |
| BGNE | 2024-06-17 | Sell | 154 | $158.24 | $24,369 | 762 |
| BGNE | 2024-06-17 | Sell | 195 | $158.58 | $30,923 | 567 |
1 of 2 issuers are covered and open a security page; the rest are on file here only.